Patient is a 47-year-old female with liver tumor.
Biopsy reveals a tumor with a very high mitotic index and many large, irregular nuclei.
TNM staging results indicate T3N1M0.
Based upon the above data, the patient has:
a. Stage III, large tumor mass spread to the lymph nodes and a distant metastasis
b. Stage IV, large tumor mass spread to the lymph nodes and a distant metastasis
c. Stage II, large tumor mass spread to lymph nodes only
d. Stage I, localized large tumor mass; no evidence of spread to lymph nodes or distant metastasis
e. Stage II, large tumor mass; no evidence of lymph node cancer, however, presence of distant metastasis
31- PET uses:
a. Ultrasound to localize tumor location
b. An antibody to localize tumors
c. X-rays to measure tumor activity
d. Radioactive glucose to measure tumor activity
32- Phase I clinical trials mainly test:
a. Is the treatment safe in humans?
b. Does the treatment stop the tumors from growing?
c. Does the treatment shrink tumors?
d. Does the treatment completely destroy the tumor